Vaxess Technologies is a preclinical stage company advancing two silk-based platforms to support next-generation vaccines that are highly potent and more easily distributed around
the world. MIMIX is a novel sustained release microneedle for delivery of vaccines, offering not only simplified administration but also dramatic enhancements to product efficacy via
“infection mimicry”. MATRIX is a formulation and drying platform to reduce the need for cold storage and shipment of vaccines, diagnostics reagents and biospecimens (blood/saliva).